MedTrace Logo

Self-sampling for Non-attenders to Cervical Cancer Screening

NCT04226313 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15000

Last updated 2026-03-23

No results posted yet for this study

Summary

The trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.

Conditions

Interventions

DIAGNOSTIC_TEST

Self-sampling by Evalyn Brush

Women will perform a cervicovaginal self-sampling at their home using Evalyn Brush.

DIAGNOSTIC_TEST

Self sampling by Evalyn Brush home or in GP´s clinic

Women will perform a cervicovaginal self-sampling at their home or the GP´s clinic using Evalyn Brush

Sponsors & Collaborators

  • National Institute for Cancer Research, Czech Republic

    collaborator OTHER

  • The Institute of Molecular and Translational Medicine, Czech Republic

    lead OTHER

Principal Investigators

  • Marian Hajduch, MD, PhD. · IMTM, Palacky University in Olomouc, Faculty of Medicine and Dentistry

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04226313 on ClinicalTrials.gov